14-day Premium Trial Subscription Try For FreeTry Free

Why Denali Therapeutics Stock Is Sinking Today

12:35pm, Monday, 26'th Jul 2021
The company reported interim results from a phase 1/2 study of its experimental Hunter syndrome drug.
SOUTH SAN FRANCISCO, Calif., July 25, 2021 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cro
Management to host webinar for analysts and investors on July 25th Management to host webinar for analysts and investors on July 25th
Denali Therapeutics (DNLI) has moved higher as of late, but there could definitely be trouble on the horizon for this company
Healthcare faces an important decision as the Supreme Court decides on the Affordable Care Act. Biotechs face an important FDA decision on approval of an Alzheimer's treatment.
Denali (DNLI) posts a wider-than-expected loss in the first quarter of 2021 due to higher R&D costs.
SOUTH SAN FRANCISCO, Calif., May 03, 2021 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cros
SOUTH SAN FRANCISCO, Calif., May 01, 2021 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cros
Denali Therapeutics Inc. (DNLI) reported earnings 30 days ago. What's next for the stock?

Denali Is Getting To Be More And More Interesting

02:09pm, Thursday, 25'th Mar 2021
Denali released some early positive data. Meanwhile its market cap has reduced by 25%.
If you think ecommerce and digital banking have accelerated in the past year, then you really need to check out promising biotech stocks. The post 7 Biotech Stocks With Catalysts That Go Far Beyond Co

Why Denali Therapeutics Stock Popped Today

03:38pm, Thursday, 11'th Mar 2021
The biotech received good news from the FDA concerning one of its pipeline candidates.
SOUTH SAN FRANCISCO, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cr
Denali Therapeutics Inc. (DNLI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
SOUTH SAN FRANCISCO, Calif., Feb. 12, 2021 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineered to cro
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE